CYP2D6 and acute myeloid leukemia: Chen et al. found that the GSTM1-null genotype in combination with the CYP1A1 and CYP2D6 heterozygous mutant genotypes was associated with an elevated risk of acute non-lymphoblastic leukemia [11].